Menú
Meet the Programme Commitee for DIA Europe 2024!
Comité del programa
-
Aimad Torqui • Division Head Medicines Evaluation Board
Medicines Evaluation Board, Netherlands -
Álmath Spooner, PhD • Head of Europe Regulatory Policy & Intelligence (RPI)
Abbvie, Ireland -
Claudia Dollins, PhD, RAC • Vice President, Precision Medicines, Global Regulatory Affairs
GlaxoSmithKline, United States -
Dima Samaha • Senior Principal, EMEA Value & Payer Evidence
IQVIA, United Kingdom -
Douglas Gregory • Senior Director, Government Affairs Strategy and Excellence
Belgium -
Esther De Vries, MS, MSc • Pharmacovigilance Assessor
CBG-MEB, Netherlands -
Emma Du Four, MBA • Regulatory and R&D Policy Professional
United Kingdom -
James Whitehead, MBA, MSc • Senior Director, Device & Digital Safety
AstraZeneca, United Kingdom -
James Ryan, MSc • Director, Global HTA Policy
AstraZeneca (Global), UK, United Kingdom -
Julie O'Brien, PhD • Head Europe and International Regulatory Policy
Pfizer, Ireland -
Marianne Lunzer, DrMed • Assessor, Dept of Clinical Trials, Federal Office for Safety in Health Care
AGES, Austria -
Matt Popkin, PhD • Senior Director, CMC Excellence, Global Regulatory Affairs
GSK, United Kingdom -
Michela Gabaldo, PharmD, MSc • VP ATMP Global Regulatory Affairs
Evotec, Italy -
Mireille Muller, DrSc, PhD, MSc • Regulatory Policy & Intelligence Director
Novartis Pharma AG, Switzerland -
Momir Radulovic • Executive Director
Slovenian Medicines and Medical Devices Agency (JAZMP), Slovenia -
Rabia Sucu • Senior Technical Advisor
Management Sciences for Health, Ukraine -
Rodrigo Palacios, MBA • Executive Director, Technical Regulatory Policy
F. Hoffmann-La Roche, Switzerland -
Ronnie Harprit Mundair • Regional Labelling Head - AfME, Canada and LATAM - Senior Director
Pfizer, United Kingdom -
Sabine Haubenreisser, PhD, MSc • Principal Scientific Administrator, Stakeholders and Communication Division
European Medicines Agency, Netherlands -
Sini Eskola, MPharm, MS, MSc • Director Regulatory Strategy
EFPIA - European Federation of Pharmaceutical Industries and Associations, Belgium -
Sofia Ribeiro, PhD • Head Regulatory Affairs CMC
Bayer US LLC, United States -
Sophie Schmitz • Managing Partner
P4A Partners for Access, Netherlands -
Thomas Wejs Møller, MBA, MSc • Director Global Regulatory Affairs - Devices
Novo Nordisk, Denmark -
Tim Chesworth • Senior Director Regulatory Affairs
AstraZeneca, United Kingdom -
Valentina Strammiello, MA • Director of Programmes
European Patients' Forum, Belgium -
Virginia Acha, PhD, MSc • AVP, Global Regulatory Policy
Merck Sharpe & Dohme LLC , United States